STOCK TITAN

[6-K] Concord Medical Services Holding Limited Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Victory Capital Holdings, Inc. (VCTR) filed a Form 4 reporting that director Alan Rappaport acquired 1,000 shares of common stock on 07/10/2025 at a reference price of $66.24 per share. The shares were issued instead of cash director fees totaling $66,250, including quarterly board fees and committee compensation.

Following the issuance, Rappaport’s direct ownership stands at 153,144 shares. He also reports 298,861 shares held indirectly through ADR Partners, an entity he controls, bringing his aggregate beneficial ownership to 452,005 shares.

The transaction is recorded under code “A” (acquisition) but represents a fee-in-kind conversion rather than an open-market purchase, limiting its signaling value about insider sentiment. No derivative securities were reported, and there is no indication of additional insider sales or purchases.

Victory Capital Holdings, Inc. (VCTR) ha presentato un Modulo 4 segnalando che il direttore Alan Rappaport ha acquisito 1.000 azioni ordinarie il 10/07/2025 al prezzo di riferimento di 66,24 $ per azione. Le azioni sono state emesse in sostituzione del compenso in contanti per il direttore, per un totale di 66.250 $, comprensivi delle commissioni trimestrali del consiglio e del compenso per le commissioni.

Dopo l’emissione, la proprietà diretta di Rappaport ammonta a 153.144 azioni. Riporta inoltre 298.861 azioni detenute indirettamente tramite ADR Partners, un’entità da lui controllata, portando la sua partecipazione complessiva a 452.005 azioni.

La transazione è registrata con il codice “A” (acquisizione) ma rappresenta una conversione fee-in-kind piuttosto che un acquisto sul mercato aperto, limitandone il valore informativo riguardo al sentimento interno. Non sono stati segnalati titoli derivati e non vi sono indicazioni di ulteriori vendite o acquisti da parte degli insider.

Victory Capital Holdings, Inc. (VCTR) presentó un Formulario 4 informando que el director Alan Rappaport adquirió 1,000 acciones ordinarias el 10/07/2025 a un precio de referencia de $66.24 por acción. Las acciones se emitieron en lugar de honorarios en efectivo para el director, por un total de $66,250, incluyendo honorarios trimestrales de la junta y compensación por comités.

Tras la emisión, la propiedad directa de Rappaport es de 153,144 acciones. También reporta 298,861 acciones mantenidas indirectamente a través de ADR Partners, una entidad que controla, elevando su propiedad beneficiaria total a 452,005 acciones.

La transacción está registrada bajo el código “A” (adquisición), pero representa una conversión de fee-in-kind en lugar de una compra en el mercado abierto, limitando su valor como señal sobre el sentimiento interno. No se reportaron valores derivados ni indicios de ventas o compras adicionales por parte de los insiders.

Victory Capital Holdings, Inc. (VCTR)는 이사 Alan Rappaport2025년 7월 10일에 보통주 1,000주를 주당 $66.24의 기준 가격으로 취득했다고 보고하는 Form 4를 제출했습니다. 이 주식들은 현금 이사 수수료 총액 $66,250(분기별 이사회 수수료 및 위원회 보상 포함) 대신 발행되었습니다.

발행 후 Rappaport의 직접 소유153,144주이며, 그가 통제하는 ADR Partners를 통해 간접적으로 보유한 298,861주도 보고하여 총 실질 소유 주식수는 452,005주입니다.

거래는 코드 “A”(취득)로 기록되었으나, 공개 시장에서의 매수가 아닌 수수료 대체 형태로 이루어져 내부자 심리에 대한 신호 가치가 제한적입니다. 파생 증권은 보고되지 않았으며 추가 내부자 매매도 없습니다.

Victory Capital Holdings, Inc. (VCTR) a déposé un formulaire 4 indiquant que le directeur Alan Rappaport a acquis 1 000 actions ordinaires le 10/07/2025 au prix de référence de 66,24 $ par action. Les actions ont été émises en lieu et place de frais de directeur en espèces totalisant 66 250 $, incluant les frais trimestriels du conseil d'administration et la rémunération des comités.

Après émission, la possession directe de Rappaport s’élève à 153 144 actions. Il déclare également 298 861 actions détenues indirectement via ADR Partners, une entité qu’il contrôle, portant sa détention bénéficiaire totale à 452 005 actions.

La transaction est enregistrée sous le code « A » (acquisition), mais représente une conversion en fee-in-kind plutôt qu’un achat sur le marché ouvert, ce qui limite sa valeur indicative quant au sentiment des initiés. Aucun titre dérivé n’a été déclaré et il n’y a aucune indication de ventes ou achats supplémentaires d’initiés.

Victory Capital Holdings, Inc. (VCTR) hat ein Formular 4 eingereicht, in dem berichtet wird, dass Direktor Alan Rappaport am 10.07.2025 1.000 Stammaktien zu einem Referenzpreis von 66,24 $ pro Aktie erworben hat. Die Aktien wurden anstelle von Barvergütungen für Direktoren in Höhe von insgesamt 66.250 $ ausgegeben, einschließlich vierteljährlicher Vorstandshonorare und Ausschussvergütungen.

Nach der Ausgabe hält Rappaport eine direkte Beteiligung von 153.144 Aktien. Zudem meldet er 298.861 Aktien, die indirekt über ADR Partners, eine von ihm kontrollierte Einheit, gehalten werden, womit sein gesamtes wirtschaftliches Eigentum bei 452.005 Aktien liegt.

Die Transaktion ist unter dem Code „A“ (Erwerb) erfasst, stellt jedoch eine Gebühren-in-Art-Umwandlung dar und keinen Kauf am offenen Markt, was den Aussagewert hinsichtlich der Insiderstimmung einschränkt. Es wurden keine Derivate gemeldet und es gibt keine Hinweise auf weitere Insiderverkäufe oder -käufe.

Positive
  • Director increases direct shareholding by 1,000 shares, signaling continued equity alignment.
  • Total beneficial ownership climbs to 452,005 shares, underscoring long-term commitment.
Negative
  • None.

Insights

TL;DR – Minor fee-based share issuance; neutral insider signal.

The 1,000-share addition is immaterial (<1% of Rappaport’s holdings) and stems from compensation elections, not discretionary buying. While it modestly lifts the director’s direct stake, the lack of open-market activity tempers bullish interpretation. Total ownership of 452k shares (≈0.6% of basic shares outstanding) maintains board-level alignment but doesn’t materially change insider ownership patterns. Overall impact for investors is neutral.

Victory Capital Holdings, Inc. (VCTR) ha presentato un Modulo 4 segnalando che il direttore Alan Rappaport ha acquisito 1.000 azioni ordinarie il 10/07/2025 al prezzo di riferimento di 66,24 $ per azione. Le azioni sono state emesse in sostituzione del compenso in contanti per il direttore, per un totale di 66.250 $, comprensivi delle commissioni trimestrali del consiglio e del compenso per le commissioni.

Dopo l’emissione, la proprietà diretta di Rappaport ammonta a 153.144 azioni. Riporta inoltre 298.861 azioni detenute indirettamente tramite ADR Partners, un’entità da lui controllata, portando la sua partecipazione complessiva a 452.005 azioni.

La transazione è registrata con il codice “A” (acquisizione) ma rappresenta una conversione fee-in-kind piuttosto che un acquisto sul mercato aperto, limitandone il valore informativo riguardo al sentimento interno. Non sono stati segnalati titoli derivati e non vi sono indicazioni di ulteriori vendite o acquisti da parte degli insider.

Victory Capital Holdings, Inc. (VCTR) presentó un Formulario 4 informando que el director Alan Rappaport adquirió 1,000 acciones ordinarias el 10/07/2025 a un precio de referencia de $66.24 por acción. Las acciones se emitieron en lugar de honorarios en efectivo para el director, por un total de $66,250, incluyendo honorarios trimestrales de la junta y compensación por comités.

Tras la emisión, la propiedad directa de Rappaport es de 153,144 acciones. También reporta 298,861 acciones mantenidas indirectamente a través de ADR Partners, una entidad que controla, elevando su propiedad beneficiaria total a 452,005 acciones.

La transacción está registrada bajo el código “A” (adquisición), pero representa una conversión de fee-in-kind en lugar de una compra en el mercado abierto, limitando su valor como señal sobre el sentimiento interno. No se reportaron valores derivados ni indicios de ventas o compras adicionales por parte de los insiders.

Victory Capital Holdings, Inc. (VCTR)는 이사 Alan Rappaport2025년 7월 10일에 보통주 1,000주를 주당 $66.24의 기준 가격으로 취득했다고 보고하는 Form 4를 제출했습니다. 이 주식들은 현금 이사 수수료 총액 $66,250(분기별 이사회 수수료 및 위원회 보상 포함) 대신 발행되었습니다.

발행 후 Rappaport의 직접 소유153,144주이며, 그가 통제하는 ADR Partners를 통해 간접적으로 보유한 298,861주도 보고하여 총 실질 소유 주식수는 452,005주입니다.

거래는 코드 “A”(취득)로 기록되었으나, 공개 시장에서의 매수가 아닌 수수료 대체 형태로 이루어져 내부자 심리에 대한 신호 가치가 제한적입니다. 파생 증권은 보고되지 않았으며 추가 내부자 매매도 없습니다.

Victory Capital Holdings, Inc. (VCTR) a déposé un formulaire 4 indiquant que le directeur Alan Rappaport a acquis 1 000 actions ordinaires le 10/07/2025 au prix de référence de 66,24 $ par action. Les actions ont été émises en lieu et place de frais de directeur en espèces totalisant 66 250 $, incluant les frais trimestriels du conseil d'administration et la rémunération des comités.

Après émission, la possession directe de Rappaport s’élève à 153 144 actions. Il déclare également 298 861 actions détenues indirectement via ADR Partners, une entité qu’il contrôle, portant sa détention bénéficiaire totale à 452 005 actions.

La transaction est enregistrée sous le code « A » (acquisition), mais représente une conversion en fee-in-kind plutôt qu’un achat sur le marché ouvert, ce qui limite sa valeur indicative quant au sentiment des initiés. Aucun titre dérivé n’a été déclaré et il n’y a aucune indication de ventes ou achats supplémentaires d’initiés.

Victory Capital Holdings, Inc. (VCTR) hat ein Formular 4 eingereicht, in dem berichtet wird, dass Direktor Alan Rappaport am 10.07.2025 1.000 Stammaktien zu einem Referenzpreis von 66,24 $ pro Aktie erworben hat. Die Aktien wurden anstelle von Barvergütungen für Direktoren in Höhe von insgesamt 66.250 $ ausgegeben, einschließlich vierteljährlicher Vorstandshonorare und Ausschussvergütungen.

Nach der Ausgabe hält Rappaport eine direkte Beteiligung von 153.144 Aktien. Zudem meldet er 298.861 Aktien, die indirekt über ADR Partners, eine von ihm kontrollierte Einheit, gehalten werden, womit sein gesamtes wirtschaftliches Eigentum bei 452.005 Aktien liegt.

Die Transaktion ist unter dem Code „A“ (Erwerb) erfasst, stellt jedoch eine Gebühren-in-Art-Umwandlung dar und keinen Kauf am offenen Markt, was den Aussagewert hinsichtlich der Insiderstimmung einschränkt. Es wurden keine Derivate gemeldet und es gibt keine Hinweise auf weitere Insiderverkäufe oder -käufe.

&nbsp;

&nbsp;

&nbsp;

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

&nbsp;

FORM&nbsp;6-K

&nbsp;

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

&nbsp;

For the month of July&nbsp;2025

&nbsp;

&nbsp;

Commission File Number: 001-34563

&nbsp;

&nbsp;

CONCORD MEDICAL SERVICES HOLDINGS LIMITED

&nbsp;

&nbsp;

Room A1-A5 26/F, East Zone, Hanwei Plaza

No.&nbsp;7 Guanghua Road, Chaoyang District,

Beijing 100020

People&rsquo;s Republic of China

(Address of principal executive office)

&nbsp;

&nbsp;

Indicate by check mark whether the registrant files or will file annual reports under cover of Form&nbsp;20-F or Form&nbsp;40-F.

&nbsp;

Form&nbsp;20-F      x &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form&nbsp;40-F      ¨

&nbsp;

Indicate by check mark if the registrant is submitting the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101(b)(1): ¨

&nbsp;

Indicate by check mark if the registrant is submitting the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101(b)(7): ¨

&nbsp;

&nbsp;

&nbsp;

&nbsp;

&nbsp;

&nbsp;

SIGNATURE

&nbsp;

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

&nbsp;

&nbsp; CONCORD MEDICAL SERVICES HOLDINGS LIMITED
&nbsp; &nbsp; &nbsp;
&nbsp; By: /s/ Jianyu Yang
&nbsp; Name: &nbsp;Jianyu Yang
&nbsp; Title: Chairman and Chief Executive Officer

&nbsp;

Date: July&nbsp;14, 2025

&nbsp;

&nbsp;

&nbsp;

&nbsp;

EXHIBIT&nbsp;INDEX

&nbsp;

Exhibit&nbsp;No. &nbsp; Description
&nbsp; &nbsp;
Exhibit&nbsp;99.1 &nbsp; Press Release: PR Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma

&nbsp;

&nbsp;

&nbsp;

&nbsp;

FAQ

How many Victory Capital (VCTR) shares did director Alan Rappaport acquire?

He received 1,000 shares of common stock on July 10, 2025.

What price was applied to the 1,000 shares?

The shares were valued at the $66.24 closing price on July 10, 2025.

What is Rappaport’s total beneficial ownership after the transaction?

He now reports 153,144 shares directly and 298,861 shares indirectly, totaling 452,005 shares.

Was this an open-market purchase?

No. The shares were issued in lieu of cash director fees, not bought on the open market.

Who holds the indirectly owned shares?

They are held by ADR Partners, an entity controlled by Mr. Rappaport.

Did the filing report any derivative securities?

No derivative securities were reported in Table II.
Concord Medical

NYSE:CCM

CCM Rankings

CCM Latest News

CCM Latest SEC Filings

CCM Stock Data

24.64M
2.31M
18%
0.11%
0.14%
Medical Care Facilities
Healthcare
Link
China
Beijing